Sinqi Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Xingqi Pharmaceutical: Legal Opinion of Beijing Jingtian Gongcheng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Shenyang Xingqi Pharmaceutical Co., Ltd.
Sinqi Pharmaceutical: Announcement on the enrollment of the first test subjects in the phase I clinical trial of SQ-22031 eye drops
Sinqi Pharmaceutical: Summary table of non-operating capital expenditure and other related capital transactions for the first half year of 2024
Sinqi Pharmaceutical: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Sinqi Pharmaceutical: Announcement on applying for credit from banks
Shenyang Xingqi Pharmaceutical: Announcement Regarding the Completion of Business Registration Changes for the Wholly-Owned Subsidiary.
Shenyang Xingqi Pharmaceutical: Announcement on Withdrawal of Pharmaceutical Registration Application.
Shenyang Xingqi Pharmaceutical: Announcement Regarding Clinical Trial Approval Notice for SQ-22031 Eye Drops.
Shenyang Xingqi Pharmaceutical: Legal Opinion of Beijing Jingtian Gongcheng Law Firm on the 2023 Annual General Meeting of Shareholders of Shenyang Xingqi Pharmaceutical Co., Ltd.
Shenyang Xingqi Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Shenyang Xingqi Pharmaceutical: Announcement on the progress of the “Double Improvement of Quality and Return” action plan
Shenyang Xingqi Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement
Sinqi Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Sinqi Pharmaceutical: Board of Directors Rules of Procedure
Sinqi Pharmaceutical: 2023 Internal Control Self-Evaluation Report
Sinqi Pharmaceutical: 2023 Annual Report Disclosure Reminder
Sinqi Pharmaceutical: Special Report on Non-operating Capital Occupation and Other Related Capital Transactions
Sinqi Pharmaceutical: Announcement on amending the “Articles of Association”
Sinqi Pharmaceutical: Announcement on holding an online briefing on the 2023 annual results
No Data
No Data